BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31051685)

  • 21. Health Care Financing Administration/American Society for Cytotechnology inspections: government assessment of cytology laboratory practice under the regulations of the Clinical Laboratory Improvement Amendments of 1988.
    Triol JH; Russell CD; Ashton PR
    Arch Pathol Lab Med; 1997 Mar; 121(3):264-6. PubMed ID: 9111114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scientific issues related to the cytology proficiency testing regulations.
    Cytopathology Education and Technology Consortium
    Acta Cytol; 2006; 50(2):191-7. PubMed ID: 16610688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Clinical Laboratory Improvement Program: not your ordinary regulatory program.
    Brophy MA
    Mil Med; 2000 Jul; 165(7 Suppl 2):48-51. PubMed ID: 10920640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-contamination in cytology processing: a review of current practice.
    Roberson J; Cuda JM; Davis Floyd AD; McGrath CM; Russell DK; Wendel-Spiczka A; VandenBussche CJ; Reynolds JP;
    J Am Soc Cytopathol; 2022; 11(4):194-200. PubMed ID: 35610099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversy continues as DHHS implements CLIA; new test category considered.
    Wash Memo Alan Guttmacher Inst; 1992 Dec; (19):2-3. PubMed ID: 12344681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approval of the Commission on Office Laboratory Accreditation for Immunohematology--HCFA. Notice.
    Fed Regist; 1997 May; 62(96):27262. PubMed ID: 10167535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of Proficiency Testing as a Tool to Improve Quality in Microbiology Laboratories.
    Stang HL; Anderson NL
    Clin Microbiol Newsl; 2013 Sep; 35(18):145-152. PubMed ID: 26726277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and Clinical Laboratory Improvement Act Program fee collection--HCFA. Final rule with comment period.
    Fed Regist; 1993 Jan; 58(11):5215-37. PubMed ID: 10171356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are you ready for a CLIA inspection?
    Spencer C; Gorove C
    Internist; 1993 Sep; 34(8):32-3. PubMed ID: 10171698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical immunohistochemistry laboratory: regulations and troubleshooting guidelines.
    Fetsch PA; Abati A
    Methods Mol Biol; 2010; 588():399-412. PubMed ID: 20012854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Has compliance with CLIA requirements really improved quality in US clinical laboratories?
    Ehrmeyer SS; Laessig RH
    Clin Chim Acta; 2004 Aug; 346(1):37-43. PubMed ID: 15234634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988--HCFA. Final rule; correction.
    Fed Regist; 1993 Sep; 58(177):48323. PubMed ID: 10171695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing risk under CLIA (Clinical Laboratory Improvement Amendments).
    Burke RL
    Med Group Manage J; 1993; 40(3):30-4. PubMed ID: 10171440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicare program; Medicare and laboratory certification program; enforcement procedures for laboratories--HCFA. Final rule.
    Fed Regist; 1992 Feb; 57(40):7218-43. PubMed ID: 10117065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.
    Crothers BA; Darragh TM; Tambouret RH; Nayar R; Barkan GA; Zhao C; Booth CN; Padmanabhan V; Tabatabai ZL; Souers RJ; Thomas N; Wilbur DC; Moriarty AT
    Arch Pathol Lab Med; 2016 Jan; 140(1):13-21. PubMed ID: 26046490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory practices for diagnosis of tuberculosis--United States, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Aug; 44(31):587-90. PubMed ID: 7623761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician office laboratory regulation: proven strategies to meet the demands of the CLIA (Clinical Laboratory Improvement Amendments).
    Lee R
    Med Staff Couns; 1993; 7(3):11-26. PubMed ID: 10171471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care.
    Kaul KL; Sabatini LM; Tsongalis GJ; Caliendo AM; Olsen RJ; Ashwood ER; Bale S; Benirschke R; Carlow D; Funke BH; Grody WW; Hayden RT; Hegde M; Lyon E; Murata K; Pessin M; Press RD; Thomson RB
    Acad Pathol; 2017; 4():2374289517708309. PubMed ID: 28815200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point of care testing: regulation and accreditation.
    Carlson DA
    Clin Lab Sci; 1996; 9(5):298-302; quiz 303-4. PubMed ID: 10163657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CLIA program; approval of the College of American Pathologists--HCFA. Notice.
    Fed Regist; 1995 Feb; 60(27):7774-80. PubMed ID: 10141154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.